FEBS Letters | |
Neomycin: a specific drug to study the inositol‐phospholipid signalling system? | |
Deeney, Jude T.1  Prentki, Marc1  Joseph, Suresh K.1  Matschinsky, Franz M.1  | |
[1] Department of Biochemistry and Biophysics and Diabetes Research Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA | |
关键词: Neomycin Aminoglycoside antibiotic Ca2+ release Inositol phospholipid Inositol phosphate; | |
DOI : 10.1016/0014-5793(86)80343-X | |
学科分类:生物化学/生物物理 | |
来源: John Wiley & Sons Ltd. | |
【 摘 要 】
Neomycin, an antibiotic previously thought to interact specifically with inositol-containing phospholipids, was found to inhibit IP3-mediated Ca2+ release from the intracellular stores of permeabilized insulinoma and liver cells. This inhibition could be relieved by increasing the IP3 concentration. Radiolabelled IP3 was found to bind tightly to columns prepared from neomycin covalently attached to glass beads. ATP was also bound by these colums. It is concluded that neomycin acts in biological systems as a weak anion exchanger and is therefore unsuitable for use as a specific tool to study the role of inositol phospholipids in intracellular signalling.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912020287784ZK.pdf | 366KB | download |